Actively Recruiting
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Led by Shanghai Hengrui Pharmaceutical Co., Ltd. · Updated on 2025-12-01
300
Participants Needed
1
Research Sites
201 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a Phase II study to explore the efficacy and safety of SHR-A2102 in combination with other anti-tumor therapies as perioperative treatment in patients with resectable non-small cell lung cancer.
CONDITIONS
Official Title
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily agree to participate and provide written informed consent
- Aged between 18 and 70 years old inclusive
- Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Have adequate organ function
- Women of childbearing age must have a negative pregnancy test and agree to use effective contraception, as must male partners of women of childbearing age
You will not qualify if you...
- Have active, known, or suspected autoimmune disease
- Have had cancers other than non-small cell lung cancer within the past 5 years
- Have or are suspected to have pneumonitis, interstitial lung disease, or serious lung diseases affecting lung function
- Have a significant history of cardiovascular or cerebrovascular disease or bleeding disorders
- Have experienced arteriovenous thrombotic events
- Have a known history of HIV infection
- Have active Hepatitis B or Hepatitis C infection
- Are allergic to any study treatment drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
J
Junli Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here